{{Rsnum
|rsid=4336372
|Chromosome=5
|position=175184337
|Orientation=plus
|GMAF=0.4412
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 50.4 | 37.2 | 12.4
| HCB | 31.4 | 44.5 | 24.1
| JPT | 27.4 | 54.0 | 18.6
| YRI | 15.0 | 46.9 | 38.1
| ASW | 25.0 | 35.7 | 39.3
| CHB | 31.4 | 44.5 | 24.1
| CHD | 22.9 | 45.0 | 32.1
| GIH | 41.0 | 46.0 | 13.0
| LWK | 18.3 | 42.2 | 39.4
| MEX | 19.0 | 46.6 | 34.5
| MKK | 23.1 | 44.9 | 32.1
| TSI | 42.2 | 43.1 | 14.7
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23555300
  |Trait=Response to anti-TNF treatment in rheumatoid arthritis
  |Title=Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis.
  |RiskAllele=C
  |Pval=3E-6
  |OR=.34
  |ORtxt=[NR] unit decrease
  |OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}